This week’s Medicare updates include additional information on denial of home health payments when required patient assessment is not received; Advanced Provider Screening phase 1 go-live; an MLN Matters article on billing for Advance Care Planning claims; and more!
This month's HIPAA Q&A answers our readers' questions about disclosures to family members, healthcare providers, and home health visits to gated communities.
How many of us have a successful mentoring program established in our organization and department? For most organizations, I would venture to say mentoring is performed on a piecemeal basis and is likely not as effective as it could be. Far too often, mentoring efforts are disorganized and lack a dedicated trainer. If any training is given, it often consists of the same general orientation afforded to all new employees, regardless of the job they will be doing.
Q: We are confused on the reporting of HCPCS code C9399 (unclassified drugs or biologicals) for new diagnostic radiopharmaceuticals and contrast agents that are approved by the FDA but don’t yet have a HCPCS code. CMS guidance states that this HCPCS code should be used until a specific HCPCS code for the item has been assigned, but we have one that is going on two years and there is not a new HCPCS code assigned yet. When we ask about it, the answers have varied.